Non-Hodgkin’s lymphoma basics

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/non-hodgkins-lymphoma-basics/id43184... Non-Hodgkin’s lymphoma is the seventh most common cancer in men and women in the United States and often misdiagnosed by primary care doctors. Symptoms may include headaches, confusion, nausea and fatigue. Jason Westin, M.D., assistant professor in Lymphoma/Myeloma at MD Anderson Cancer Center, discusses the basics of non-Hodgkin’s lymphoma including symptoms, diagnosis, treatment and...

New bladder cancer screening tool detects more tumors in early stages

submitted by: mdanderson

Blue light cystoscopy (Cysview) reveals more than traditional white light cystoscopy since the bladder cancer cells that become visible in blue light may be invisible with traditional white light. A cystoscopy is a diagnostic procedure used to examine the bladder. Ashish Kamat, M.D., associate professor in Urology at MD Anderson Cancer Center, explains why blue light cystoscopy is so effective in detecting bladder cancer and discusses this disease in general.

Breast cancer patients offers health tips

submitted by: mdanderson

Exercise, healthy diet and doing activities to keep you mentally alert are just some of the tips MD Anderson breast cancer patient, Doris Thomas, offers in this video.

biosights: June 10, 2013 - Netrin Throws Anchor Cells into the Breach

submitted by: JCB
Cell invasion through basement membranes is crucial for both normal development and cancer metastasis but relatively little is known about the process because it is difficult to observe in vivo. By imaging the invasion of anchor cells during C. elegans development, Hagedorn et al. reveal that, after invadopodia-like structures form an initial breach in the basement membrane, localized netrin signaling helps generate a stable invasive protrusion that widens the gap and directs the cell across...

De geschiedenis van de Pathologie, een reis door de archieven

submitted by: LUMC_PA_MD
Technologische vooruitgang in de pathologie. Een reis door de archieven. Van anatomisch theater naar “gepersonaliseerde geneeskunde”. Deze video presentatie is gemaakt ten behoeve van de promotie van Ronald van Eijk d.d. 8 mei 2013 op het proefschrift: Technological Advances in Molecular Pathology. A journey into the Archives De presentatie geeft een populair wetenschappelijk beeld van de ontwikkelingen in de Pathologie. In de loop der eeuwen zijn er vele revolutionaire, breed...

Recent study on drug for newly diagnosed glioblastoma patients

submitted by: mdanderson

Bevacizumab offers no benefit for newly diagnosed glioblastoma (brain) cancer patients, MD Anderson-led study finds. Mark Gilbert, M.D., professor in Neuro-Oncology at MD Anderson Cancer Center, and Minesh Mehta, M.D., Ph.D., chairman of Radiation Oncology at the University of Maryland School of Medicine, discuss their study in the front line setting for the treatment of glioblastoma.